Navigation Links
MetaStat, Inc. Executes Two New Licenses
Date:4/27/2012

THE WOODLANDS, Texas, April 27, 2012 /PRNewswire/ -- MetaStat, Inc. (OTCBB: MTST) announced today that it has executed two additional license agreements to patent applications and technology from the Albert Einstein College of Medicine of Yeshiva University. The first license agreement covers U.S. Patent Application No. 12/998,237 entitled "An In Vivo Quantitative Screening Test for Anti-Metastasis Treatment Efficacy"; inventors: Jeffrey Edward Segall, John S. Condeelis, Dmitriy Kedrin, Jacco van Rheenan and Bojanna Gligorijevic. The second license includes two areas of intellectual property, U.S. Patent Application No. 11/659,514 entitled "Isolation, Gene Expression, and Chemotherapeutic Resistance of Motile Cancer Cells"; inventor John S. Condeelis (and its accompanying Canadian and European Patent Applications) and U.S. Provisional Patent Application (pending) entitled "Human Invasion Signature for Prognosis of Metastatic Risk"; inventors: John S. Condeelis and Antonia Patsialou.

We believe the technologies covered in these patent applications expand MetaStat's intellectual property in the field of highly metastatic cells.  Metastatic cells are the cancer cells that have developed the ability to transform themselves both physically and behaviorally from proiferative to metastatic. They migrate within the tumor, hone in on the tumor vasculature, form complexes on the surface of the blood vessels, and gain entry to the blood stream where they are carried to distant organs and tissues of the body to form metastases. These distant site metastases are the cause of the vast majority of fatalities from solid tumor cancers including approximately 90% of fatalities from breast cancer.

We believe the technology underlying "An In Vivo Quantitative Screening Test for Anti-Metastasis Treatment Efficacy" is expected to provide drug developers at MetaStat and potential corporate partners with drug development tools to develop the next generation
'/>"/>

SOURCE MetaStat, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PhotoVoltaic Solar Cells, Inc. Completes Share Exchange with MetaStat, Inc.
2. MetaStat, Inc. Completes Share Exchange with PhotoVoltaic Solar Cells, Inc.
3. Ampio Pharmaceuticals Executes License and Development Agreement with Daewoong Co. Ltd. to Commercialize Zertane™ in South Korea
4. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
5. Adeona Executes Manufacturing and Supply Agreement with TG United for reaZin™
6. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
7. Alexza Executes $15 million Working Capital Loan with Hercules Technology Growth Capital, Inc.
8. Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
9. Obecure Executes Licensing and Clinical Supply Agreement With Farmaceutici-Formenti SPA for Extended Release Formulation of Betahistine
10. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
11. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014 Pharmaceutical Care Management ... today outlined policy solutions that could reduce prescription fraud ... Hill briefing, " Prescription Opioid Abuse: Fighting Back on ... Reform and PCMA. The briefing featured ... prescription drug abuse and fraud. The Centers for Disease ...
(Date:9/29/2014)... YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 Esophagoscopes ... market data on the EU5 Esophagoscopes & Gastroscopes ... US dollars, volume (in units) and average prices ... Video Esophagoscopes, Flexible Non-Video (Fibre) Gastroscopes and Flexible ...
(Date:9/29/2014)... BEIJING , Sept. 29, 2014  Following US and ... accelerator, the China Food and Drug Administration (CFDA) has ... in the country. According to the International ... people are diagnosed with cancer every year in ... types including lung, gastric, colorectal, liver and esophageal cancers ...
Breaking Medicine Technology:PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 2EU5 Esophagoscopes & Gastroscopes Market Outlook to 2020 3Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 2Chinese clinics and cancer patients to benefit from Elekta's Versa HD radiation therapy system 3
... DIEGO, Dec. 18 Ambrx Inc. today announced ... with Merck & Co. Inc. to,develop a novel ... Factor 21 (FGF-21) for the treatment of type ... The collaboration utilizes Ambrx,s proprietary protein technology,ReCODE(TM), ...
... Epeius Biotechnologies,Corporation announced today that the company ... Rexin-G(R) from the Philippine Bureau of Food ... lead product as a safe,and effective treatment ... as a tumor-targeted anticancer agent, that actively ...
Cached Medicine Technology:Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc. 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 2ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer 3
(Date:9/30/2014)... DC (PRWEB) September 30, ... **MEDIA ADVISORY** , From:        Hope ... Barnwell, 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org ... Hope® Celebration , Date:        Thursday, ... Address:    The Army and Navy ...
(Date:9/30/2014)... Barbara Williamson shares her life story for the ... Life: Love, Sex and Commitment" . As co-founder with ... highly successful and controversial Sandstone Retreat in Malibu, California, ... started what became known as the hub of the ... outrageously popular, with a membership reaching 500 and nearly ...
(Date:9/30/2014)... 2014 Computer Resources of America, ... based in New York City, has been awarded ... to transform, manage, and support the IT environment ... a leading provider of innovative services that enable ... The contract will cover the four NY-metro ...
(Date:9/30/2014)... September 30, 2014 Bibliomotion is ... Redefining Leadership for the Complex Social Age by ... 2014). , In the book, the authors apply their leadership ... which to view the conversations, actions, and behaviors that leaders ... world. Click here to read a review of ...
(Date:9/30/2014)... 2014 RBS Reputation Management is reported to ... Your Name’. , The service name may surprise as ... the service this odd name, a management professional said, “This ... this name. We have named the service ‘Remove Your Name’ ... get rid of all those posts which light their name ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 2Health News:The Autobiography "An Extraordinary Life: Love, Sex and Commitment" Embraces Healthy Sexual Behavior 3Health News:CRA Awarded Managed Services Contract for Large NYC Nonprofit 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 2Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 3Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 4Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 5Health News:The Social Leader: new Bibliomotion book redefines leadership for the Social Age 6Health News:RBS Reputation Management Announces A New Service ‘Remove Your Name’ 2
... virus should be monitored for high blood pressure, expert ... Adults with the skin disease shingles appear to be ... the area around the eyes, researchers report. , Previous ... exact frequency and risk for these phenomena are still ...
... types of human papillomavirus (HPV), a sexually transmitted virus, ... Current guidelines prioritize HPV vaccination of pre-adolescent girls, which ... but the value of vaccinating boys in the United ... School of Public Health (HSPH) researchers found that if ...
... Study finds two-thirds of those with the mysterious illness infected ... About two-thirds of patients with chronic fatigue syndrome sampled in ... , The finding, albeit preliminary, has raised hopes that there ... thus, down the line, treatments for the disease. , "This ...
... Reportlinker.com announces that a new market research report ... Reportlinker Adds Germany Wound Care Management Market Analysis ... http://www.reportlinker.com/p0151443/Reportlinker-Adds-Germany-Wound-Care-Management-Market-Analysis-and-Forecasts-to-2015.html , ... Analysis and Forecasts to 2015 report provides key ...
... Biomonitoring Study Detects Four Chemicals from EPA,s Recently-Announced Top ... Physicians for Social Responsibility (PSR), American Nurses Association (ANA) ... Chemicals In Health Care," the first investigation of ... , Today,s announcement was made on a national teleconference ...
... cause of death worldwide. Our evolutionary struggle with this ... UC Riverside. Population geneticist Leonard Nunney will ... Struggle With Cancer," at 7 p.m., Thursday, Oct. 15, in ... p.m. Seating is open. "Cancer is unlike other diseases," ...
Cached Medicine News:Health News:Shingles Raises Stroke Risk: Study 2Health News:Shingles Raises Stroke Risk: Study 3Health News:Vaccinating boys against human papillomavirus not cost-effective 2Health News:Vaccinating boys against human papillomavirus not cost-effective 3Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 2Health News:Retrovirus May Be at Root of Chronic Fatigue Syndrome 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 2Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 3Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 4Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 5Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 6Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 7Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 9Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 10Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 11Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 12Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 13Health News:Reportlinker Adds Germany Wound Care Management Market Analysis and Forecasts to 2015 14Health News:Toxic Chemicals Found in Doctors and Nurses 2Health News:Evolutionary struggle with cancer is focus of public lecture at UC Riverside 2
Used for vascular access. Supplied sterile in peel-open packages. Intended for one-time use....
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used to introduce large devices for vascular intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: